See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2015_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 617,620,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 72,361,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,055,000 |
| 3 | remainder_Assets | 14,029,000 |
| 4 | LiabilitiesCurrent | 57,499,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 125,705,388 |
| 9 | ResearchAndDevelopmentExpense | 7,084,052 |
| 10 | remainder_Expenses | -26,887,306 |
| 11 | remainder_Revenues | 443,721,215 |
| 12 | remainder_NetIncome | -118,497,021 |
| 13 | remainder_ComprehensiveNetIncome | -32,715 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 711,065,000 |
| 1 | Liabilities | 57,499,000 |
| 2 | Expenses | 105,902,134 |
| 3 | Revenues | 443,721,215 |
| 4 | StockholdersEquity | 653,566,000 |
| 5 | NetIncome | 219,322,060 |
| 6 | ComprehensiveNetIncome | 219,305,702 |
| 7 | BaseVar | 718,358,542 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.28 |
| 9 | EconomicCapitalRatio | 4.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
